Loading
Sinopharm Tech Holdings Ltd. Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by HEUNG Pik Lun, was filed 05 May 2026.
Sinopharm Tech Holdings Ltd.: what insiders have been doing
This page follows insider dealings at Sinopharm Tech Holdings Ltd. as filed with HKEX, a company from the Technology sector. Between 23 October 2025 and 23 October 2026, 1 insider published 33 filings.
Open-market activity splits into 32 purchases totalling €131k and 1 sale totalling €7,645; 1 insider sit on the buying side and 1 insider on the selling side. Netting one side against the other leaves €123k of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 1 senior executive among the declarants. HEUNG Pik Lun filed the largest purchase, €17k, on 20 November 2025.
Across the 1,315 companies tracked on its exchange, the median is 4 filings; at 33 filings, this issuer sits above that mark. Since 2017, the database holds 42 purchases and 19 sales by insiders of the company.
The last insider purchase was made public on 5 May 2026, 172 days ago. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade.
In the same sector, recent insider purchases at Hanza AB and Lime Technologies AB (publ) also feature in our signals. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Insider Decl.
75
Thresholds
n/a
Buy Volume
€3M
42 ops. · all time
Sell Volume
€19M
19 ops. · all time
Who traded when
BuySaleHEUNG Pik Lun32 buys1 sale
Since the insiders bought
- -36.1%Entry HK$0.25 · Close at T+90 HK$0.16
- -89.7%Entry HK$5.57 · Close at T+365 HK$0.57
- -89.7%Entry HK$5.57 · Close at T+365 HK$0.57
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 25,807 of 26,280 companies
9.1
score / 100
Value11
Quality7
FCF yld-11%
Earn yld-17%
EV/EBITDA38.6x
ROE·
Gross mgn12%
Net mgn-48%
Debt/EBITDA14.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended June 2024 · cache
HK$0.19
Analyst consensus
Income statement
RevenueHK$41.3M
Gross profitHK$5M12% margin
EBITDAHK$5M12% margin
Net income-HK$19.7M-20.1% margin
Valuation
PER (trailing)15.6x
Beta1.59
Balance sheet & cash
Market capHK$119.1M
Total debtHK$73.3M
Free Cash Flow-HK$12.6M
Profitability & ownership
ROA-13.3%
% insiders75.0%
% institutions0.0%
Last declaration on 6 October 2026
Declarations75 total
380,000 shares@ HK$0.17740.068% mcap55.6% of flowShareXHKGHKEX:DA20261005E00301
60,000 shares@ HK$0.260.012% mcap27.8% of flowShareXHKGHKEX:DA20260504E00670
Canonical exit: 29 Jul 2026 (T+90)
50,000 shares@ HK$0.240.0092% mcap21.5% of flowShareXHKGHKEX:DA20260425E00001
Canonical exit: 22 Jul 2026 (T+90)
60,000 shares@ HK$0.2450.011% mcap26.1% of flowShareXHKGHKEX:DA20260421E00650
Canonical exit: 19 Jul 2026 (T+90)
50,000 shares@ HK$0.270.013% mcap24.5% of flowShareXHKGHKEX:DA20260330E00490
Canonical exit: 25 Jun 2026 (T+90)
100,000 shares@ HK$0.3252.6% of flowShareXHKGHKEX:DA20260127E00559
Canonical exit: 22 Apr 2026 (T+90)
20,000 shares@ HK$0.310.5% of flowShareXHKGHKEX:DA20260121E00603
Canonical exit: 15 Apr 2026 (T+90)
100,000 shares@ HK$0.3142.5% of flowShareXHKGHKEX:DA20260116E00788
Canonical exit: 14 Apr 2026 (T+90)
30,000 shares@ HK$0.310.7% of flowShareXHKGHKEX:DA20260116E00786
Canonical exit: 13 Apr 2026 (T+90)
200,000 shares@ HK$0.3155.0% of flowShareXHKGHKEX:DA20260109E00634
Canonical exit: 9 Apr 2026 (T+90)
110,000 shares@ HK$0.302.6% of flowShareXHKGHKEX:DA20260109E00633
Canonical exit: 6 Apr 2026 (T+90)
120,000 shares@ HK$0.3253.1% of flowShareXHKGHKEX:DA20260102E00556
Canonical exit: 29 Mar 2026 (T+90)
50,000 shares@ HK$0.3151.2% of flowShareXHKGHKEX:DA20251229E00381
Canonical exit: 24 Mar 2026 (T+90)
50,000 shares@ HK$0.311.2% of flowShareXHKGHKEX:DA20251229E00380
Canonical exit: 23 Mar 2026 (T+90)
120,000 shares@ HK$0.30252.9% of flowShareXHKGHKEX:DA20251229E00379
Canonical exit: 22 Mar 2026 (T+90)
70,000 shares@ HK$0.3151.7% of flowShareXHKGHKEX:DA20251215E00408
Canonical exit: 12 Mar 2026 (T+90)
100,000 shares@ HK$0.352.8% of flowShareXHKGHKEX:DA20251215E00407
Canonical exit: 11 Mar 2026 (T+90)
50,000 shares@ HK$0.3351.3% of flowShareXHKGHKEX:DA20251215E00406
Canonical exit: 10 Mar 2026 (T+90)
200,000 shares@ HK$0.32255.1% of flowShareXHKGHKEX:DA20251205E00545
Canonical exit: 4 Mar 2026 (T+90)
60,000 shares@ HK$0.32081.5% of flowShareXHKGHKEX:DA20251205E00544
Canonical exit: 3 Mar 2026 (T+90)
150,000 shares@ HK$0.3253.9% of flowShareXHKGHKEX:DA20251205E00543
Canonical exit: 2 Mar 2026 (T+90)
30,000 shares@ HK$0.3250.8% of flowShareXHKGHKEX:DA20251201E00329
Canonical exit: 25 Feb 2026 (T+90)
410,000 shares@ HK$0.349611.6% of flowShareXHKGHKEX:DA20251127E00490
Canonical exit: 22 Feb 2026 (T+90)
280,000 shares@ HK$0.33547.6% of flowShareXHKGHKEX:DA20251125E00345
Canonical exit: 19 Feb 2026 (T+90)
90,000 shares@ HK$0.31942.3% of flowShareXHKGHKEX:DA20251125E00344
Canonical exit: 18 Feb 2026 (T+90)
25 of 75 declarations
About Sinopharm Tech Holdings Ltd.
Sinopharm Tech Holdings Ltd. is a technology company listed on the Hong Kong Stock Exchange. It focuses on the development and provision of technological solutions in the healthcare sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
